Concepts (85)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Peptide Elongation Factors | 4 | 2005 | 27 | 0.480 |
Why?
|
| Proto-Oncogenes | 4 | 2005 | 60 | 0.450 |
Why?
|
| Transcription Factors | 7 | 2007 | 1717 | 0.430 |
Why?
|
| DNA-Binding Proteins | 6 | 2005 | 1261 | 0.370 |
Why?
|
| Neoplasm Proteins | 4 | 2005 | 552 | 0.280 |
Why?
|
| Transcriptional Elongation Factors | 6 | 2007 | 24 | 0.230 |
Why?
|
| Oncogene Proteins, Fusion | 4 | 2003 | 137 | 0.230 |
Why?
|
| Receptors, Mineralocorticoid | 1 | 2005 | 11 | 0.220 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 5 | 2005 | 78 | 0.160 |
Why?
|
| Histone-Lysine N-Methyltransferase | 4 | 2005 | 171 | 0.140 |
Why?
|
| Transfection | 4 | 2007 | 883 | 0.100 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2005 | 557 | 0.100 |
Why?
|
| Amino Acid Sequence | 3 | 2002 | 2003 | 0.080 |
Why?
|
| Molecular Sequence Data | 3 | 2002 | 2894 | 0.070 |
Why?
|
| Apoptosis | 2 | 2007 | 1752 | 0.070 |
Why?
|
| HeLa Cells | 3 | 2007 | 519 | 0.070 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2003 | 850 | 0.060 |
Why?
|
| Blotting, Northern | 2 | 2002 | 239 | 0.060 |
Why?
|
| COS Cells | 1 | 2005 | 163 | 0.050 |
Why?
|
| Sequence Alignment | 2 | 2001 | 353 | 0.050 |
Why?
|
| Coiled Bodies | 1 | 2003 | 2 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2002 | 463 | 0.050 |
Why?
|
| Immunosorbent Techniques | 1 | 2002 | 11 | 0.050 |
Why?
|
| Sequence Homology | 1 | 2002 | 26 | 0.050 |
Why?
|
| Binding Sites | 2 | 2002 | 1159 | 0.050 |
Why?
|
| Aspartic Acid | 1 | 2002 | 62 | 0.050 |
Why?
|
| Retroviridae | 1 | 2002 | 74 | 0.050 |
Why?
|
| Serine | 1 | 2002 | 106 | 0.040 |
Why?
|
| Glutamic Acid | 1 | 2002 | 136 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 2002 | 209 | 0.040 |
Why?
|
| Zinc Fingers | 1 | 2002 | 59 | 0.040 |
Why?
|
| Precipitin Tests | 1 | 2001 | 101 | 0.040 |
Why?
|
| Animals | 5 | 2005 | 28950 | 0.040 |
Why?
|
| Bone Marrow | 1 | 2002 | 421 | 0.040 |
Why?
|
| Mice | 4 | 2002 | 12718 | 0.040 |
Why?
|
| Protein Binding | 2 | 2002 | 1557 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2002 | 480 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 1816 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2002 | 529 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2002 | 615 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2001 | 293 | 0.040 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2002 | 331 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2005 | 1133 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 1028 | 0.040 |
Why?
|
| Leukemia | 1 | 2001 | 309 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2002 | 448 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 682 | 0.030 |
Why?
|
| Proteins | 1 | 2002 | 803 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2005 | 2020 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2007 | 1841 | 0.030 |
Why?
|
| Mutation | 1 | 2005 | 4408 | 0.020 |
Why?
|
| Humans | 6 | 2007 | 98223 | 0.020 |
Why?
|
| Cell Line | 2 | 2003 | 2482 | 0.020 |
Why?
|
| Peptide Mapping | 1 | 2007 | 24 | 0.020 |
Why?
|
| snRNP Core Proteins | 1 | 2003 | 9 | 0.010 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 2003 | 20 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2003 | 106 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2003 | 61 | 0.010 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2003 | 69 | 0.010 |
Why?
|
| Herpes Simplex Virus Protein Vmw65 | 1 | 2002 | 5 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 2003 | 245 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 2002 | 63 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2002 | 43 | 0.010 |
Why?
|
| Autoantigens | 1 | 2003 | 145 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2002 | 125 | 0.010 |
Why?
|
| Luciferases | 1 | 2002 | 128 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2003 | 264 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2002 | 291 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2002 | 276 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 994 | 0.010 |
Why?
|
| Rabbits | 1 | 2002 | 582 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2002 | 201 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2007 | 1790 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 2894 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2002 | 1110 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2002 | 978 | 0.010 |
Why?
|
| RNA | 1 | 2003 | 595 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2003 | 752 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2002 | 914 | 0.010 |
Why?
|
| Gene Expression | 1 | 2002 | 1321 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2002 | 727 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2001 | 2856 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2002 | 1566 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2001 | 1395 | 0.010 |
Why?
|
| Male | 1 | 2007 | 47195 | 0.000 |
Why?
|